Published Guidance, NICE advice and quality standards

Skip to filtersSkip to results

Skip to results

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 51 to 75 of 120

TitleReference numberPublishedLast updated
Givosiran for treating acute hepatic porphyriaHST16
Glaucoma: diagnosis and managementNG81
Headaches in over 12s: diagnosis and managementCG150
HealthVCF for detecting vertebral compression fractures on CT scansMIB267
Heart valve disease presenting in adults: investigation and managementNG208
Hysteroscopic mechanical tissue removal (hysteroscopic morcellation) for uterine fibroidsIPG704
Immunoscore for predicting risk of colon cancer relapseMIB269
Inclisiran for treating primary hypercholesterolaemia or mixed dyslipidaemiaTA733
Inducing and maintaining normothermia using temperature modulation devices to improve outcomes after stroke or subarachnoid haemorrhageIPG701
Inducing labourNG207
Inducing labourQS60
Isatuximab with carfilzomib and dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal)TA727
Ixekizumab for treating axial spondyloarthritisTA718
Laparoscopic removal of uterine fibroids with power morcellationIPG703
Laparoscopic renal denervation for loin pain haematuria syndromeIPG709
Lateral elbow resurfacing for arthritisIPG705
Liraglutide for managing obesity in people aged 12 to 17 years (terminated appraisal)TA749
Looked-after children and young peopleNG205
Lung texture analysis for measuring interstitial lung diseasesMIB272
Magnetic resonance therapy for knee osteoarthritisIPG702
Melatonin for treating sleep disorders in adults who are blindES38
Mexiletine for treating the symptoms of myotonia in non-dystrophic myotonic disordersTA748
Midostaurin for treating advanced systemic mastocytosisTA728
MMprofiler for prognostic risk classification in multiple myelomaMIB270
Mogamulizumab for previously treated mycosis fungoides and Sézary syndromeTA754

Results per page

  1. 10
  2. 25
  3. 50
  4. All